Omega Diagnostics Group PLC
ODX.L · LSE
3/31/2023 | 9/30/2022 | 3/31/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Market Cap | £5,662 | £4,292 | £6,610 | £77,260 |
| - Cash | £5,115 | £2,712 | £1,605 | £4,698 |
| + Debt | £74 | £135 | £370 | £2,652 |
| Enterprise Value | £621 | £1,715 | £5,375 | £75,214 |
| Revenue | – | – | – | – |
| % Growth | – | – | – | – |
| Gross Profit | – | – | – | – |
| % Margin | – | – | – | – |
| EBITDA | – | – | – | – |
| % Margin | – | – | – | – |
| Net Income | – | – | – | – |
| % Margin | – | – | – | – |
| EPS Diluted | – | – | – | – |
| % Growth | – | – | – | – |
| Operating Cash Flow | – | – | – | – |
| Capital Expenditures | – | – | – | – |
| Free Cash Flow | – | – | – | – |